Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment of relapsing-remitting multiple sclerosis: current and future algorithms.
[Diagnosis and treatment of neuromyelitis optica.]
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Finding benefit in stressful uncertain circumstances: relations to social support and stigma among women with unexplained illnesses.
[Monoclonal antibodies for the treatment of multiple sclerosis].
Hyperinsulinemia in newly diagnosed patients with multiple sclerosis.
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis.
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
ZSTK474, a novel PI3K inhibitor, modulates human CD14(+) monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis.
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Familial clustering in Italian progressive-onset and bout-onset multiple sclerosis.
Bedside tested ocular motor disorders in multiple sclerosis patients.
Epstein-barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis.
Emergency medical care of multiple sclerosis patients: primary data from the mount sinai resource utilization in multiple sclerosis project.
Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.
Dalfampridine: review of its efficacy in improving gait in patients with multiple sclerosis.
Multiple Sclerosis in the Levant: A Regional Consensus Statement.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Level of mobility limitations and falls status in persons with multiple sclerosis.
Baló's concentric sclerosis: imaging findings and pathological correlation.
Transplantation of autologous adipose stem cells lacks therapeutic efficacy in the experimental autoimmune encephalomyelitis model.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Current management of relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
472
473
474
475
476
477
478
479
480
…
next ›
last »